Fujifilm injects $2B into large-scale cell culture manufacturing site in US
Fujifilm injects $2B into large-scale cell culture manufacturing site in US 08 January 2021 | News
Photo Credit: shutterstock.com
FUJIFILM Corporation is making an investment of more than 200 Billion yen ($2 Billion) to establish a new large-scale cell culture production site in the United States to accelerate the growth of its biopharmaceutical contract development and manufacturing business (CDMO).
FUJIFILM Diosynth Biotechnologies, a subsidiary of FUJIFILM Corporation, with development and manufacturing facilities across the U.S.A., U.K., and Denmark will operate the new facility. This new facility will offer large-scale cell culture manufacturing of bulk drug substance with 8 x 20,000L bioreactors (physical volume), with the potential to expand and add a further 24 x 20,000L bioreactors based on market demand. In addition to drug substance manufacture, the facility will also provide comm
Fujifilm to invest over $2bn to build large scale US cell culture facility Tokyo headquartered, Fujifilm Corporation, has announced a new US$2bn (£1.4bn/€1.5bn) investment to establish a new large-scale biopharma site in the US.
The facility will be operated by its subsidiary, Fujifilm Diosynth Biotechnologies, which has locations in Teesside, UK, in North Carolina and Texas in the US and in Hillerød, Denmark.
The move serves to further underline Fujiflim’s ambitions within the contract development and manufacturing (CDMO) space, following its US$928m investment, announced last year, to expand its site in Hillerød, Denmark, and the capital it is ploughing into its UK and US facilities.
Novel endoscopic technique improves detection of upper GI tract tumors
Recently there have been significant advances on several fronts in the ongoing war against cancer of the alimentary tract. Now, Japanese researchers report the development of another weapon: Linked Color Imaging (LCI), a novel endoscopic technique that improves detection of cancer by viewing the upper digestive tract mucosa under illumination that combines specific wavelengths of light to intensify subtle color variations indicative of neoplastic change.
Upper gastrointestinal (GI) endoscopy is routinely performed to detect tumorous changes or neoplasia in the pharynx, esophagus, and stomach and is conventionally done under White Light Imaging (WLI). Using the innovative LASEREO system developed by the Fujifilm Corporation, LCI technology balances white light with narrow-band short wavelength light in a specific ratio that deepens and enhances the contrast of red and white hues, thus intensifying nuances of muco
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global cell culture market is projected to reach USD 33.1 billion by 2025 from USD 19 billion in 2020, at a CAGR of 11.8% during the forecast period.
The growth of this market is majorly driven by the growing awareness about the benefits of cell culture-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, and the launch of advanced cell culture products. On the other hand, the high cost of cell biology research and the lack of proper infrastructure for cell-based research activities are the major factors restraining this market s growth.